FDA Notices, Guidances Should Reflect St. John's Wort Interaction - CHPA
This article was originally published in The Tan Sheet
Executive Summary
Center for Drug Evaluation & Research health advisories and guidances should be amended to communicate potential interactions of St. John's wort with certain types of Rx drugs, CHPA tells FDA.